Copyright
©2014 Baishideng Publishing Group Co.
World J Gastroenterol. Mar 14, 2014; 20(10): 2695-2703
Published online Mar 14, 2014. doi: 10.3748/wjg.v20.i10.2695
Published online Mar 14, 2014. doi: 10.3748/wjg.v20.i10.2695
Table 2 Quality of studies on cytomegalovirus in ulcerative colitis assessed according to modified New-Castle Ottawa Scale
Total | Outcome | Comparability | Selection | Ref. |
1 | * | Al-Zafiri et al[14], 2012 | ||
3 | * | ** | Criscuoli et al[17], 2011 | |
4 | * | * | ** | Kim et al[12], 2012 |
1 | * | Kopylov et al[16], 2013 | ||
3 | * | ** | Maconi et al[10], 2011 | |
3 | * | ** | Maruyama et al[15], 2012 | |
4 | * | * | ** | Omiya et al[8], 2010 |
4 | * | *** | Roblin et al[13], 2011 | |
1 | * | Zeki et al[9], 2010 | ||
24/54 (44.4%) | 4/9 (44.4%) | 4/18 (22.2%) | 16/27 (59.3%) | Total |
- Citation: Kopylov U, Eliakim-Raz N, Szilagy A, Seidman E, Ben-Horin S, Katz L. Antiviral therapy in cytomegalovirus-positive ulcerative colitis: A systematic review and meta-analysis. World J Gastroenterol 2014; 20(10): 2695-2703
- URL: https://www.wjgnet.com/1007-9327/full/v20/i10/2695.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i10.2695